COVID-19 vaccines in adult cancer patients with solid tumours undergoing active treatment: Seropositivity and safety. A prospective observational study in Italy
European Journal of Cancer(2021)
Abstract
•Patients with cancer are at great risk of serious complications and death from coronavirus disease (COVID-19).•257 patients with cancer vaccinated against COVID-19, 75.88% showed seroconversion.•219 of the 257 patients (85.21%) were on active anticancer treatment.•No Grade 3–4 side-effects were reported.•Male sex and active anticancer treatment negatively influence serologic response.
MoreTranslated text
Key words
COVID-19,SARS-COV-2,Vaccine,Cancer patients,Anticancer treatment,Seroconversion,Antibodies
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined